We are live on ! Find out more
AC

Armistice Capital Portfolio holdings

AUM $5.62B
1-Year Est. Return 36.06%
This Fund
S&P 500
This Quarter Est. Return
+6.37%
1 Year Est. Return
+36.06%
3 Year Est. Return
+44.14%
5 Year Est. Return
+38.37%
10 Year Est. Return
+188.88%
AUM
$1.53B
AUM Growth
+$224M
Cap. Flow
+$172M
Cap. Flow %
11.23%
Top 10 Hldgs %
40.36%
Holding
96
New
31
Increased
23
Reduced
14
Closed
23

Top Buys

Rank Stock Value
1
EPC icon
Edgewell Personal Care
EPC
+$50.2M
2
MNK
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
+$38.2M
3
SJM icon
J.M. Smucker
SJM
+$36.4M
4
INCY icon
Incyte
INCY
+$29.3M
5
TBPH icon
Theravance Biopharma
TBPH
+$28M

Top Sells

Rank Stock Value
1
FRPT icon
Freshpet
FRPT
+$51.6M
2
UTHR icon
United Therapeutics
UTHR
+$43.6M
3
CAKE icon
Cheesecake Factory
CAKE
+$37.1M
4
POST icon
Post Holdings
POST
+$29.7M
5
ASRT
Assertio
ASRT
+$28.4M

Sector Composition

Rank Sector Weight
1 Healthcare 37.79%
2 Consumer Discretionary 23.39%
3 Consumer Staples 8.62%
4 Communication Services 0.74%
5 Technology 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TBPH icon
26
Theravance Biopharma
TBPH
$875M
$26.8M 1.75%
+1,180,000
New +$28M
HAIN icon
27
CALL
Hain Celestial
HAIN
$45.9M
$23.8M 1.56%
800,000
-142,300
-15% -$4.08M
SMPL icon
28
Simply Good Foods
SMPL
$991M
$21.1M 1.38%
+1,460,000
New +$19.6M
BGS icon
29
B&G Foods
BGS
$301M
$20.9M 1.37%
+700,000
New +$18.8M
PGNX
30
DELISTED
Progenics Pharmaceuticals Inc
PGNX
$20.4M 1.33%
2,536,000
+136,000
+6% +$1.04M
LNW
31
DELISTED
Light & Wonder
LNW
$18.1M 1.18%
+368,000
New +$19.4M
EPC icon
32
CALL
Edgewell Personal Care
EPC
$1.33B
$17.7M 1.15%
+350,000
New +$16.1M
LRMR icon
33
Larimar Therapeutics
LRMR
$385M
$15.3M 1%
125,000
+50,000
+67% +$4.25M
ENTA icon
34
Enanta Pharmaceuticals
ENTA
$362M
$14.4M 0.94%
124,000
-8,000
-6% -$798K
ALXN
35
DELISTED
Alexion Pharmaceuticals
ALXN
$13.9M 0.91%
+112,000
New +$13.1M
CELG
36
DELISTED
Celgene Corp
CELG
$13.9M 0.91%
+175,000
New +$14.5M
APRN
37
DELISTED
Blue Apron Holdings, Inc. Class A Common Stock
APRN
$13.4M 0.88%
22,222
+309
+1% +$146K
SBBP
38
DELISTED
Strongbridge Biopharma plc.
SBBP
$12.9M 0.85%
2,158,000
-1,214,000
-36% -$8.88M
PZZA icon
39
Papa John's
PZZA
$1.03B
$12.7M 0.83%
+250,000
New +$14M
DFRG
40
DELISTED
Del Frisco's Restaurant Group, Inc. Common Stock
DFRG
$12.6M 0.82%
+1,000,000
New +$14.5M
ONCE
41
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
$12.4M 0.81%
150,000
-30,000
-17% -$2.32M
PRTK
42
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$11.5M 0.75%
1,132,000
+552,000
+95% +$6.25M
ACHN
43
DELISTED
Achillion Pharmaceuticals
ACHN
$11.3M 0.74%
4,000,000
-296,000
-7% -$1.01M
BBY icon
44
Best Buy
BBY
$19B
$10.4M 0.68%
+140,000
New +$10.3M
QVCGA
45
DELISTED
QVC Group Inc Series A
QVCGA
$10.4M 0.68%
+10,094
New +$11.2M
CENN icon
46
Cenntro
CENN
$8.46M
$10.1M 0.66%
+2
New +$12.5M
ATEC icon
47
Alphatec Holdings
ATEC
$1.42B
$9.63M 0.63%
3,230,414
+738,000
+30% +$2.62M
KPRX icon
48
Kiora Pharmaceuticals
KPRX
$11.1M
$8.9M 0.58%
3,112
+2,891
+1,308% +$8.16M
VYGR icon
49
Voyager Therapeutics
VYGR
$180M
$8.44M 0.55%
+432,000
New +$8.54M
ASRT
50
DELISTED
Assertio
ASRT
$7.86M 0.51%
19,632
-69,951
-78% -$28.4M
1
2
3 4

Similar funds

CRC
Curi RMB Capital Chicago, Illinois $5.62B AUM 18.93% 1-Year Est. Return
RMDI
R.M. Davis Inc Portland, Maine $5.63B AUM 21.26% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
DWM
Diversify Wealth Management Sandy, Utah $5.61B AUM 19.63% 1-Year Est. Return
DCP
DSM Capital Partners Palm Beach Gardens, Florida $5.66B AUM 27.45% 1-Year Est. Return
EW
Evoke Wealth Los Angeles, California $5.57B AUM 23.85% 1-Year Est. Return
AIM
Alphinity Investment Management Sydney, Australia $5.68B AUM 26.72% 1-Year Est. Return
O
Ossiam Paris, France $5.69B AUM 30.95% 1-Year Est. Return

Armistice Capital's Q2 2018 Portfolio in Review

As of Q2 2018, Armistice Capital held 96 positions worth $1.53B, up 17% from $1.31B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Armistice Capital deployed $172M of net new capital in Q2 2018, opening 31 new positions and adding to 23 existing holdings. Its largest new stake was Edgewell Personal Care: 1,092,000 shares worth $55.1M.

By sector, the portfolio is most concentrated in Healthcare at 38% of assets, down from 42% a quarter earlier, followed by Consumer Discretionary and Consumer Staples.

On the sell side, the largest reduction was Assertio, an estimated $28.4M trimmed.

  • Armistice Capital's largest Q2 2018 buy was Edgewell Personal Care: 1,092,000 shares worth $55.1M.
  • Armistice Capital added most to Despegar.com in Q2 2018, an estimated $25.3M increase.
  • Armistice Capital's biggest Q2 2018 reduction was Assertio, cutting an estimated $28.4M.
  • Armistice Capital fully exited Freshpet in Q2 2018, selling an estimated $51.6M.
  • Armistice Capital's ten largest holdings make up 40% of its $1.53B portfolio in Q2 2018.
  • Armistice Capital opened 31 new positions and closed 23 in Q2 2018.
  • Armistice Capital's portfolio value rose 17% quarter-over-quarter to $1.53B.

Based on Armistice Capital's 13F filing for Q2 2018, filed 14 Aug 2018.